miR-338-5p promotes anoikis in esophageal squamous cell carcinoma by targeting HRP-3
碩士 === 國立臺灣大學 === 生物科技研究所 === 107 === Esophageal cancer (EC) is the 7th most common cancer and ranks 6th of mortality worldwide among all the other cancer types. Currently, the most common therapeutic strategy is concurrent chemoradiotherapy (CCRT). However, the respond rate of CCRT remains below 40...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2019
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/p47t9m |